1. Home
  2. OGN vs NVST Comparison

OGN vs NVST Comparison

Compare OGN & NVST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OGN
  • NVST
  • Stock Information
  • Founded
  • OGN 1923
  • NVST 2018
  • Country
  • OGN United States
  • NVST United States
  • Employees
  • OGN N/A
  • NVST N/A
  • Industry
  • OGN Biotechnology: Pharmaceutical Preparations
  • NVST Medical/Dental Instruments
  • Sector
  • OGN Health Care
  • NVST Health Care
  • Exchange
  • OGN Nasdaq
  • NVST Nasdaq
  • Market Cap
  • OGN 3.9B
  • NVST 3.3B
  • IPO Year
  • OGN N/A
  • NVST 2019
  • Fundamental
  • Price
  • OGN $14.50
  • NVST $18.70
  • Analyst Decision
  • OGN Hold
  • NVST Hold
  • Analyst Count
  • OGN 3
  • NVST 14
  • Target Price
  • OGN $21.33
  • NVST $20.79
  • AVG Volume (30 Days)
  • OGN 4.5M
  • NVST 2.2M
  • Earning Date
  • OGN 02-13-2025
  • NVST 02-05-2025
  • Dividend Yield
  • OGN 7.68%
  • NVST N/A
  • EPS Growth
  • OGN 120.97
  • NVST N/A
  • EPS
  • OGN 5.04
  • NVST N/A
  • Revenue
  • OGN $6,409,000,000.00
  • NVST $2,503,300,000.00
  • Revenue This Year
  • OGN $3.11
  • NVST N/A
  • Revenue Next Year
  • OGN $2.55
  • NVST $2.94
  • P/E Ratio
  • OGN $2.89
  • NVST N/A
  • Revenue Growth
  • OGN 4.21
  • NVST N/A
  • 52 Week Low
  • OGN $13.58
  • NVST $15.15
  • 52 Week High
  • OGN $23.10
  • NVST $25.64
  • Technical
  • Relative Strength Index (RSI)
  • OGN 37.20
  • NVST 38.26
  • Support Level
  • OGN $14.39
  • NVST $17.70
  • Resistance Level
  • OGN $15.15
  • NVST $20.86
  • Average True Range (ATR)
  • OGN 0.52
  • NVST 0.82
  • MACD
  • OGN -0.02
  • NVST -0.31
  • Stochastic Oscillator
  • OGN 8.63
  • NVST 21.46

About OGN Organon & Co.

Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars, and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.

About NVST Envista Holdings Corporation

Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals. The company's business consists of two segments comprising Specialty Products and Technologies and Equipment and Consumables. The Company's Specialty Products & Technologies segment develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics, and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. The Company's Equipment & Consumables segment manufactures dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems.

Share on Social Networks: